With its pipeline expanding beyond its initial focus on in vivo programming of myeloid cells, for which the company took its initial name, Myeloid Therapeutics has rebranded as Create Medicines and ...

After axing a wide swath of federal research projects and grants, a recent slew of awards offers a glimpse into the kinds of science the second Trump administration wants to back: in vivo cell ...

The program at John Theurer Cancer Center is the largest in New Jersey, offering advanced cell-based treatments and numerous research trials. A multidisciplinary team committed to patient-centered ...

Biology and quantum physics often seem like they belong to separate worlds. Living cells function in warm, noisy environments, full of constant motion, while quantum technologies usually need ...

Some Fairfield school students will see a change in the district’s cell phone policy when they start next week. Like all other schools in the state, Fairfield City School district had to create a new ...

Stellantis, a car manufacturer, announced on Wednesday that it will discontinue its hydrogen fuel-cell technology programme and not launch a new range of hydrogen powered vehicles this year as the ...

As the hydrogen market is showing no development prospect at mid-term, Stellantis has decided to discontinue its hydrogen fuel cell technology development program. Series production of ...

MPI-DS researchers revealed how simple, tunable interactions between cellular components can lead to complex structures and functions without needing membranes. Non-reciprocal interactions between ...

The tumor suppressor p53 is activated by a range of cellular stresses including DNA damage, oncogenic signals, and nutrient deprivation. Upon activation, p53 transcriptionally upregulates an extensive ...

Collaborative research defines a novel approach to understanding how certain proteins called transcription factors determine which genetic programs will drive cell growth and maturation. The method, ...

Summary: Collaborative research led by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center defines a novel approach to understanding how certain proteins called ...